{"id":25821,"date":"2013-01-30T18:51:00","date_gmt":"2013-01-30T18:51:00","guid":{"rendered":"https:\/\/www.padtinc.com\/2013\/01\/30\/seven-case-studies-on-product-and-medical-device-development\/"},"modified":"2022-04-01T17:34:23","modified_gmt":"2022-04-02T00:34:23","slug":"seven-case-studies-on-product-and-medical-device-development","status":"publish","type":"post","link":"https:\/\/www.padtinc.com\/2013\/01\/30\/seven-case-studies-on-product-and-medical-device-development\/","title":{"rendered":"Seven Case Studies on Product and Medical Device Development"},"content":{"rendered":"

This morning we added the seventh case study highlighting some customer stories to PADT\u2019s new website<\/a>.  These short documents highlight a project that our product and medical device development teams worked on with a variety of customers, from Nissan to a medical device inventor.  <\/p>\n

You can view them<\/a> under the Successes<\/a> portion of our website, or browse the list below:<\/p>\n

\n

\"Clearview <\/picture>THE WORLD’S FIRST AND ONLY FDA APPROVED TOTAL ARTIFICIAL HEART<\/p>\n

SynCardia has chosen to work with PADT based on their ability to develop close personal relationships, to create and implement engineering solutions rapidly, and to support SynCardia\u2019s innovative drive for our life-saving technology\u201d <\/q>\u2014 Douglas A Nutter, COO, SynCardia Systems, Inc.<\/cite><\/p>\n

SynCardia turned to PADT Medical to carry out a comprehensive series of product verification testing within a very challenging timeframe.  Continuous and successful collaboration between PADT and SynCardia professionals guaranteed the program\u2019s success. <\/p>\n

READ FULL STORY<\/a> <\/p>\n<\/div>\n

\n

\"Clearview <\/picture>CLEARVIEW: A NOVEL MEDICAL MEASUREMENT DEVICE <\/p>\n

\n

\u201cFor the last 2 years we have worked with PADT to develop our ClearView technology. Their team has helped us with many aspects of product development and commercialization. They have been a very valuable asset and I would highly recommend them to any startup that needs to navigate the pathway to market.\u201d<\/q>\u2014 Tom Blondi, President, EPIC Research & Diagnostics<\/cite><\/p>\n<\/blockquote>\n

From 2010 – 2012, PADT worked with EPIC to help them develop their ClearView diagnostic technology. PADT provided engineering, quality, manufacturing, and regulatory support. During this period, EPIC was able to raise over $6 million in private investment, achieve 510(k) submission, conduct a clinical trial at a Johns Hopkins affiliate with devices delivered by PADT, and transfer the product to manufacturing with a local contract manufacturer. <\/p>\n

READ FULL STORY <\/p>\n<\/div>\n

\n

\"High <\/picture> A COMPACT HIGH PRESSURE HYDROGEN PUMP<\/p>\n

\n

PADT has demonstrated strong concept creation and development testing abilities \u2013 and have done so with very short time schedules. PADT was in charge of a key component development for our Fuel Cell System, and accomplished it as planned. Owing to PADT’s challenging spirit, Nissan was able to lease the 2005 model FCV’s to some customers in the early period of 2006. In addition, Nissan has been able to continue the FCV leasing program for five years with PADT’s reliable support.<\/q>\u2014 Arai Takayuki, Senior Manager, EV Systems Laboratory, Nissan Motor Company<\/cite><\/p>\n<\/blockquote>\n

PADT worked with Nissan for 4 years to develop a high pressure, high performance hydrogen pump. We have now delivered over 200 working systems and have supported fielded vehicles since 2006.<\/p>\n

READ FULL STORY<\/a> <\/p>\n<\/div>\n

\n

\"Germicical <\/picture>GERMICIDAL LIGHT FOR ENDOTRACHEAL AND TRACHEOSTOMY TUBES<\/p>\n

\n

The PADT experience was a positive one from my first phone conversation with them to the delivery of the end product. The engineers delivered a prototype that was exactly what I envisioned in a short 8 weeks. PADT will be my choice in the future.\u201d \u2014 Bob Rife, R.R.T.<\/cite><\/p>\n<\/blockquote>\n

In 8 short weeks PADT Medical transformed a recently patented invention into a functional prototype. This novel Endotracheal Tube includes a germicidal light to reduce the risk of pneumonia in patients requiring prolonged airway intubation. This device is a good example of PADT’s ability to quickly convert an inventors ideas into a working, functional prototype.<\/p>\n

READ FULL STORY<\/p>\n<\/div>\n

\n

\"Portable <\/picture>PORTABLE FUEL CELL POWER SUPPLY<\/p>\n

PADT worked with PolyFuel for 18 months to develop a fuel cell based, laptop power supply that was powered from a methanol fuel stock. We started with a blank sheet and developed a POC system that included the fuel cell stack, all of the custom components and controls, and was hybridized with a Lithium-ion battery pack. During that period Polyfuel was able to raise Venture Capital to develop their product.<\/p>\n

READ FULL STORY<\/p>\n<\/div>\n

\n

\"Portable <\/picture>CLINICAL SPECIMEN COLLECTION SYSTEM<\/p>\n

The ReadyFreezer will rapidly freeze biospecimens collected from any tissue, using any surgical retrieval device, and in any hospital or clinical setting to preserve key biomarkers.  This project took full advantage of PADT\u2019s internal simulation and analysis capabilities as well as our in-house rapid prototyping services.<\/p>\n

READ FULL STORY<\/p>\n<\/div>\n

\n

\"Endoscopic <\/picture>AN ENDOSCOPIC TOOL FOR THE TREATMENT OF OBESITY<\/p>\n

\n

For the last 3 years I have worked with PADT Medical as a physician-inventor of medical devices. Their engineering team is professional, punctual, and responsible. Their management is exemplary. I recommend PADT Medical to any potential Client.<\/q>\u2014 Charles J. Filipi M.D., Medical Director, SafeStitch Medical, Inc.<\/cite><\/p>\n<\/blockquote>\n

In 2006, PADT was approached by a physician who had developed intellectual property that centered on endoscopic treatments for obesity and was founding a new company called SafeStich Medical. PADT served as SafeStitch’ engineering team for several years, developed a suite of related products, helped them achieve 510-k status on their first product, and supported their effort to build a permanent engineering organization. In June of 2010, SafeStitch raised $5 Million of capital to help commercialize their technologies.<\/p>\n

READ FULL STORY<\/p>\n<\/div>\n

If you are interested in learning more about our Product Development team or PADT Medical, contact us and we will be more than happy to discuss your needs.<\/p>\n","protected":false},"excerpt":{"rendered":"

This morning we added the seventh case study highlighting some customer stories to PADT\u2019s new website.  These short documents highlight […]<\/p>\n","protected":false},"author":33,"featured_media":24434,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[694,897,617,799,491],"post-podcast":[],"_links":{"self":[{"href":"https:\/\/www.padtinc.com\/wp-json\/wp\/v2\/posts\/25821"}],"collection":[{"href":"https:\/\/www.padtinc.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.padtinc.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.padtinc.com\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/www.padtinc.com\/wp-json\/wp\/v2\/comments?post=25821"}],"version-history":[{"count":0,"href":"https:\/\/www.padtinc.com\/wp-json\/wp\/v2\/posts\/25821\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.padtinc.com\/wp-json\/wp\/v2\/media\/24434"}],"wp:attachment":[{"href":"https:\/\/www.padtinc.com\/wp-json\/wp\/v2\/media?parent=25821"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.padtinc.com\/wp-json\/wp\/v2\/categories?post=25821"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.padtinc.com\/wp-json\/wp\/v2\/tags?post=25821"},{"taxonomy":"post-podcast","embeddable":true,"href":"https:\/\/www.padtinc.com\/wp-json\/wp\/v2\/post-podcast?post=25821"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}